What, according to you, were the various challenges faced by the companies involved in the disease diagnostics space during the pandemic?
As COVID-19 was a novel virus, detecting, containing, treating and managing the disease proved to be difficult for everyone. Lockdowns across the world to contain the disease posed additional logistical burden. Test, Trace and Treat became the diktat to fight COVID-19 and 'Testing' came under the spotlight.
Initially we faced a challenge in procurement and supply of test kits, reagents and other consumables. This was resolved by working closely with our reliable and sturdy network of suppliers. ICMR quickly validating the newly launched test kits also came in as a huge help.
COVID also forced us to think outside the box- literally, when we set-up a BSL2 level Container Lab in our National Reference Lab in Rohini, Delhi. This helped us processing greater volumes of samples simply by providing a place to unbox and add buffer to the samples before the actual testing started. With this, we were able to insulate our lab premises and staff from threat of COVID.
As everyone was dealing with the unknown, teething troubles with various states in terms of compliance, operations, reporting and pricing were also faced.
Which approaches and techniques are considered suitable (and safe) for diagnosis of infectious diseases today?
Infectious diseases are caused by Bacteria, Viruses, Fungi and Parasites and the clinical symptoms are often a mix complex of fever, cough, cold, diarrhea, rashes, etc. which are generally site specific. The best way to diagnose infectious diseases is to go for site-specific sampling and subject it to PCR (Polymerase Chain Reaction) that detects genetic material from a specific organism. This is the fastest, most sensitive and specific way to detect the causative agent of the infection.
Esta historia es de la edición December 2022 de Healthcare Radius.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 8500 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición December 2022 de Healthcare Radius.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 8500 revistas y periódicos.
Ya eres suscriptor? Conectar
ADDRESSING INDIA'S RURAL CARE GAP
Lakhs of rural Indians lack access to healthcare services. Learn the ways India can improve healthcare accessibility in its rural areas.
iMeUsWe unveils at-home DNA testing services
iMeUsWe and MapMyGenome's at-home DNA testing to offer health and ancestry insights.
CAR T-CELL THERAPY: A PROMISING CANCER TREATMENT ADVANCEMENT
Employing genetically modified immune cells to attack tumors, CAR T-cell therapy offers new hope for cancer patients.
LEADING WITH INNOVATION
\"Every regional market presents a unique set of challenges and opportunities,\" said Ms Zahabiya Khorakiwala, Managing Director, Wockhardt Hospitals Group, during Healthcare Radius Leadership Vidcast.
OVERCOMING INDIA'S AMR CHALLENGE
India faces a growing threat of antimicrobial resistance (AMR). Experts warn of superbugs and ineffective treatments. Is there hope? Read on to find out.
SOCC launches online second opinion for pediatric care
SOCC’s online second opinion consultations for pediatric care aims to bridge the gap in pediatric healthcare services in India.
Clove Dental opens 12 clinics in a single day
Clove Dental marks its 13th anniversary with nationwide expansion. Get full details.
BM Birla Heart Hospital launches cardiac care program
BM Birla Heart Hospital partners with Dozee for Al-powered cardiac care program.
PD Hinduja Hospital goes digital for infection control
Ropes in Ibhar Technologies for infection control, patient safety, and auditing automation.
Maruti Suzuki marks one year of cardiac care in rural Gujarat
Maruti Suzuki celebrates one year of providing advanced cardiac care in rural Gujarat.